Loberamisal doses of 20mg, 40mg, and 60mg show no significant difference from placebo
Trial shows loberamisal may help patients after a stroke
This Phase 2 randomized controlled trial evaluated loberamisal in 240 patients with acute ischaemic stroke within 48 hours of symptom onset.…
A new trial looks at how different doses of loberamisal affect recovery for people who have just suffered a stroke.
Phase 3 Trial Protocol Evaluating Intravenous Loberamisal for Acute Ischaemic Stroke Management
Trial Plans to Test Loberamisal for Acute Ischaemic Stroke
This Phase 3 trial evaluates intravenous loberamisal in patients with acute ischaemic stroke to determine its efficacy in improving function…
A new clinical trial is being planned to see if the drug loberamisal can improve functional outcomes for people who have recently suffered a…